Flu epidemic seems to be emerging More and more people in the Netherlands have the flu. The number of people with flu increased significantly last week.
New: NEVO online 2021 RIVM published a new online edition of the Dutch food composition database (NEVO).
Flu jab for additional groups The flu jab is offered free of charge every year to people aged 60 years and older, and to people who are at higher risk of becoming seriously ill from the flu virus due to medical reasons
More attention needs to be paid to the safe recycling of waste According to the National Institute for Public Health and the Environment (RIVM) there needs to be a greater (international) focus on, and increased awareness of, the safe recycling of waste.
Menthol facilitates inhalation of tobacco smoke, even when you cannot taste it Even when menthol cannot be tasted, the substance makes it easier to inhale tobacco smoke. This way, menthol makes smoking more attractive for young and novice smokers who are not yet used to inhaling sharp, pungent tobacco smoke.
Long-term symptoms more common after Lyme disease More than a quarter of people with Lyme disease continue to have long-term symptoms that lead to limitations in daily life even after treatment.
Method for safe and sustainable recycling of waste The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.
Last winter’s flu epidemic was short and mild. And then COVID-19 arrived. The flu epidemic in the winter of 2019/2020 was mild and lasted only 5 weeks.
RIVM international circular economy knowledge partner As of 7 December 2020, RIVM has become a knowledge partner of the international Platform for Accelerating the Circular Economy (PACE).
Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.